C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/22/2011	CA2430013C Transgenic transchromosomal rodents for making human antibodies
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/22/2011	CA2257826C Helicobacter pylori adhesin binding group antigen
11/17/2011	WO2011143665A1 Treatment methods
11/17/2011	WO2011143614A1 Enhanced death receptor agonists
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011143545A1 Heterodimeric proteins and methods for producing and purifying them
11/17/2011	WO2011143414A1 RECOMBINANTLY PRODUCED ANTIBODIES TARGETING ErbB SIGNALING MOLECULES AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE
11/17/2011	WO2011143408A1 Use of neuropilin-1 antagonists for the treatment of cancer
11/17/2011	WO2011143348A1 Antibodies to tumor endothelial marker 7r
11/17/2011	WO2011143318A2 Anti-fgfr2 antibodies
11/17/2011	WO2011143307A1 High concentration antibody formulations
11/17/2011	WO2011142545A2 Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
11/17/2011	WO2011142465A1 Novel protein and use thereof
11/17/2011	WO2011142461A1 Antibody for diagnosing amyotrophic lateral sclerosis (als)
11/17/2011	WO2011141823A2 Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists
11/17/2011	WO2011141653A1 Novel mutated humanized 12g4 antibodies and the fragments thereof against the human anti-müllerian hormone receptor type ii
11/17/2011	WO2011119888A3 N-cadherin: target for cancer diagnosis and therapy
11/17/2011	WO2011117648A3 Disulfide stabilised antibodies and fragments thereof
11/17/2011	WO2011117423A9 Immunoglobulin single variable domains directed against cxcr7
11/17/2011	WO2011089183A3 Anticoagulant antidotes
11/17/2011	WO2011088196A3 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
11/17/2011	WO2011081366A3 Beef-specific age determination marker containing the p21 protein
11/17/2011	WO2011077133A3 Method of treatment and screening method
11/17/2011	WO2011060272A3 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
11/17/2011	WO2011044336A3 Human domain antibodies against components of the human insulin-like growth factor (igf) system
11/17/2011	WO2011006914A3 Antagonists, uses & methods for partially inhibiting tnfr1
11/17/2011	WO2010139469A8 Antibodies against human ccn1 and uses thereof
11/17/2011	WO2010136562A3 Moraxella catarrhalis antigens
11/17/2011	US20110283426 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
11/17/2011	US20110283419 Regulation of Cotton Fiber Growth by Extracellular Nucleotides and Ectoapyrases
11/17/2011	US20110283376 Methods of Modifying Eukaryotic Cells
11/17/2011	US20110282037 Antibody preparation
11/17/2011	US20110282036 Bsa-specific antibodies
11/17/2011	US20110282035 Rage Fusion Proteins, Formulations And Methods Of Use Thereof
11/17/2011	US20110282034 Prevention and treatment of complement-associated eye conditions
11/17/2011	US20110282033 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/17/2011	US20110281856 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
11/17/2011	US20110281802 Composition for treatment and prevention of hair loss and premature graying of hair
11/17/2011	US20110281801 Prediction and prevention of preeclampsia
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281796 Novel activin receptor and uses thereof
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281752 Beta-secretase enzyme compositions and methods
11/17/2011	US20110281365 Protein-based assays for screening of the ige-receptor interaction
11/17/2011	US20110281348 Agonist anti-trkc antibodies and methods using same
11/17/2011	US20110281302 Compositions and methods of treating disease with fgfr fusion proteins
11/17/2011	US20110281299 Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
11/17/2011	US20110281285 Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
11/17/2011	US20110281284 Novel liver cancer marker
11/17/2011	US20110281283 Yeast cell wall components and detection thereof
11/17/2011	US20110281279 CIRCULATING Epha2 RECEPTOR
11/17/2011	US20110281277 Composition, kit, and method for diagnosing colorectal cancer or ovarian cancer
11/17/2011	US20110281260 Ribonucleic acid binding motif protein 20 sequence variants
11/17/2011	US20110281258 Human Immunodeficiency Virus And Uses Thereof
11/17/2011	US20110280930 Products and methods for stimulating an immune response
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease
11/17/2011	US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
11/17/2011	US20110280891 Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
11/17/2011	US20110280890 Prodrugs of cc-1065 analogs
11/17/2011	US20110280888 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
11/17/2011	US20110280885 Cancer immunotherapy
11/17/2011	US20110280884 Anti-cd98 antibody
11/17/2011	US20110280883 Fully human anti-epidermal growth factor receptor antibodies
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280881 Novel anti-hsp90 monoclonal antibody
11/17/2011	US20110280880 Prevention, treatment and diagnosis of p.gingivalis infection
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280877 Inhibition of B7-H1/CD80 interaction and uses thereof
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/17/2011	US20110280872 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof
11/17/2011	US20110280869 Methods of preventing or treating inflammatory or autoimmune disorders by administering cd2 antagonists in combination with other prophylactic or therapeutic agents
11/17/2011	US20110280868 Methods of preventing or treating t cell malignancies by administering anti-cd2 antagonists
11/17/2011	US20110280866 Anti-cd 160 monoclonal antibodies and uses thereof
11/17/2011	US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280813 Neuraminidase inhibitors and uses thereof
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	CA2800311A1 Anti-fgfr2 antibodies
11/17/2011	CA2799217A1 Recombinantly produced antibodies targeting erbb signaling molecules and methods of use thereof for the diagnosis and treatment of disease
11/17/2011	CA2799177A1 Enhanced death receptor agonists
11/17/2011	CA2799046A1 Il-1 binding proteins
11/17/2011	CA2798888A1 High concentration antibody formulations
11/17/2011	CA2798336A1 Novel mutated humanized 12g4 antibodies and the fragments thereof against the human anti-mullerian hormone receptor type ii
11/17/2011	CA2798328A1 Yeast cell wall components and detection thereof
11/17/2011	CA2797720A1 Humanized and chimeric monoclonal antibodies to cd47
11/17/2011	CA2793545A1 Treatment methods
11/16/2011	EP2386864A1 Diagnosis and monitoring of Ischemia
11/16/2011	EP2386863A1 Diagnosis and monitoring of multiple organ failure
11/16/2011	EP2386862A1 Methods and kits for diagnosing appendicitis
11/16/2011	EP2386859A2 Diagnostic tumor markers
11/16/2011	EP2386638A2 Method for isolation of soluble polypeptides
11/16/2011	EP2386577A2 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 1494